Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

117
Delayed Quote. Delayed London Stock Exchange - 07/25 11:35:13 am
1423 GBp   -3.16%
19m ago GLAXOSMITHKLINE : PRESS: Glaxo Has Option To Separate Consumer Healthcare B..
3d ago AstraZeneca results to get lift from bid foe Pfizer
3d ago GLAXOSMITHKLINE : Glaxo pair face trial in China
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern
Recommend:
0

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
19m ago GLAXOSMITHKLINE : PRESS: Glaxo Has Option To Separate Consumer Healthcare Busine..
3d ago AstraZeneca results to get lift from bid foe Pfizer
3d ago GLAXOSMITHKLINE : Glaxo pair face trial in China
3d ago GLAXOSMITHKLINE : Glaxo To "Thoroughly Investigate" Syria Misconduct Claims
3d ago GLAXOSMITHKLINE : *jpmorgan cuts glaxosmithkline price target to 1370 pence - 'n..
3d ago GLAXOSMITHKLINE : Facing Bribery Allegations In Syria - Reuters (PRESS)
3d ago GLAXOSMITHKLINE : *ubs cuts glaxosmithkline to 'sell' ('neutral') - price target..
3d ago GLAXOSMITHKLINE : seeks approval for world's first malaria vaccine
4d ago GLAXOSMITHKLINE : FDA approves Flonase allergy relief for sale over-the-counter ..
4d agoDJGLAXOSMITHKLINE : FDA OK's Flonase for Sale Over the Counter in U.S.
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF